Phosphorylation of GSK-3β by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes

Journal of Clinical Investigation

Volumn 118, Issue 7, 2008, Pages 2506-2515

  Kawasaki, Yosuke ^a   Kugimiya, Fumitaka ^a   Chikuda, Hirotaka ^a   Kamekura, Satoru ^a   Ikeda, Toshiyuki ^a   Kawamura, Naohiro ^a   Saito, Taku ^a   Shinoda, Yusuke ^a   Higashikawa, Akiro ^a   Yano, Fumiko ^a   Ogasawara, Toru ^a   Ogata, Naoshi ^a   Hoshi, Kazuto ^a   Hofmann, Franz ^b   Woodgett, James R ^c   Nakamura, Kozo ^a   Chung, Ung Il ^a   Kawaguchi, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIC GMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; ALKALINE PHOSPHATASE; AXIN PROTEIN; CGMP DEPENDENT PROTEIN KINASE II; CGMP-DEPENDENT PROTEIN KINASE II; COLLAGEN TYPE 10; COLLAGENASE 3; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HIGH MOBILITY GROUP PROTEIN; LITHIUM CHLORIDE; REPRESSOR PROTEIN; SOX-9 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME DEFICIENCY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; GROWTH RETARDATION; HYPERTROPHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STEM CELL; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL LINE; CONGENITAL MALFORMATION; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION; GENETICS; GROWTH PLATE; HELA CELL; HUMAN; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ALKALINE PHOSPHATASE; ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE X; CYCLIC GMP-DEPENDENT PROTEIN KINASES; GENE EXPRESSION; GLYCOGEN SYNTHASE KINASE 3; GROWTH PLATE; HELA CELLS; HIGH MOBILITY GROUP PROTEINS; HUMANS; LITHIUM CHLORIDE; MATRIX METALLOPROTEINASE 13; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PHOSPHORYLATION; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 46749134835     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JC135243     Document Type: Article

References (42)

1. Kronenberg, H.M. 2003. Developmental regulation of the growth plate. Nature. 423:332-336.
2. Chusho, H., et al. 2001. Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc. Natl. Acad. Sci. U. S. A. 98:4016-4021.
3. Tamura, N., et al. 2004. Critical roles of the guany-lyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc. Natl. Acad. Sci. U. S. A. 101:17300-17305.
4. Bartels, C.F., et al. 2004. Mutations in the trans-membrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am. J. Hum. Genet. 75:27-34.
5. Schulz, S. 2005. C-type natriuretic peptide and guanylyl cyclase B receptor. Peptides. 26:1024-1034.
6. Pfeifer, A., et al. 1996. Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science. 274:2082-2086.
7. Pfeifer, A., et al. 1999. Structure and function of cGMP-dependent protein kinases. Rev. Physiol. Biochem. Pharmacol. 135:105-149.
8. Pfeifer, A., et al. 1998. Defective smooth muscle regulation in cGMP kinase I-deficient mice. EMBO J. 17:3045-3051.
9. Chikuda, H., et al. 2004. Cyclic GMP-dependent protein kinase II is a molecular switch from proliferation to hypertrophic differentiation of chondrocytes. Genes Dev. 18:2418-2429.
10. Doble, B.W., and Woodgett, J.R. 2003. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116:1175-1186.
11. Holmbeck, K. 2005. Collagenase in cranial morphogenesis. Cells Tissues Organs. 181:154-165.
12. Akiyama, H., Chaboissier, M.C., Martin, J.F., Schedl, A., and de Crombrugghe, B. 2002. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16:2813-2828.
13. Takeda, S., Bonnamy, J.P., Owen, M.J., Ducy, P., and Karsenty, G. 2001. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 15:467-481.
14. Ornitz, D.M. 2005. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev. 16:205-213.
15. Yasoda, A., et al. 2004. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat. Med. 10:80-86.
16. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., and Leder, P. 1996. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84:911-921.
17. Hoeflich, K.P., et al. 2000. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature. 406:86-90.
18. Huang, L.F., Fukai, N., Selby, P.B., Olsen, B.R., and Mundlos, S. 1997. Mouse clavicular development: analysis of wild-type and cleidocranial dysplasia mutant mice. Dev. Dyn. 210:33-40.
19. Dong, Y.F., Soung do, Y., Schwarz, E.M., O'Keefe, R.J., and Drissi, H. 2006. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J. Cell Physiol. 208:77-86.
20. Hartmann, C., and Tabin, C.J. 2000. Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development. 127:3141-3159.
21. Yano, F., et al. 2005. The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner. Biochem. Biophys. Res. Commun. 333:1300-1308.
22. Tamamura, Y., et al. 2005. Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J. Biol. Chem. 280:19185-19195.
23. Akiyama, H., et al. 2004. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 18:1072-1087.
24. Schlossmann, J., and Hofmann, F. 2005. cGMP-dependent protein kinases in drug discovery. Drug Discov. Today. 10:627-634.
25. Hunziker, E.B. 1994. Mechanism of longitudinal bone growth and its regulation by growth plate chondrocytes. Microsc. Res. Tech. 28:505-519.
26. Wilsman, N.J., Farnum, C.E., Leiferman, E.M., Fry, M., and Barreto, C. 1996. Differential growth by growth plates as a function of multiple parameters of chondrocytic kinetics. J. Orthop. Res. 14:927-936.
27. Kronenberg, H.M. 2006. PTHrP and skeletal development. Ann. N. Y. Acad. Sci. 1068:1-13.
28. Pilz, R.B., and Casteel, D.E. 2003. Regulation of gene expression by cyclic GMP. Circ. Res. 93:1034-1046.
29. Miyazawa, T., et al. 2002. Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification. Endocrinology. 143:3604-3610.
30. Doble, B.W., Patel, S., Wood, G.A., Kockeritz, L.K., and Woodgett, J.R. 2007. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Dev. Cell. 12:957-971.
31. MacAulay, K., et al. 2007. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism. Cell Metab. 6:329-337.
32. Patel, S., Doble, B., and Woodgett, J.R. 2004. Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged sword? Biochem. Soc. Trans. 32:803-808.
33. Dominguez, I., and Green, J.B. 2001. Missing links in GSK3 regulation. Dev. Biol. 235:303-313.
34. Papadopoulou, D., Bianchi, M.W., and Bourouis, M. 2004. Functional studies of shaggy/glycogen synthase kinase 3 phosphorylation sites in Drosophila melanogaster. Mol. Cell. Biol. 24:4909-4919.
35. Ding, V.W., Chen, R.H., and McCormick, F. 2000. Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling. J. Biol. Chem. 275:32475-32481.
36. Fukumoto, S., et al. 2001. Akt participation in the Wnt signaling pathway through Dishevelled. J. Biol. Chem. 276:17479-17483.
37. Itaka, K., et al. 2007. Bone regeneration by regulated in vivo gene transfer using biocompatible polyplex nanomicelles. Mol. Ther. 15:1655-1662.
38. Ohba, S., et al. 2007. Identification of a potent combination of osteogenic genes for bone regeneration using embryonic stem (ES) cell-based sensor. FASEB J. 21:1777-1787.
39. Kamekura, S., et al. 2006. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum. 54:2462-2470.
40. Shukunami, C., et al. 1997. Cellular hypertrophy and calcification of embryonal carcinoma-derived chondrogenic cell line ATDC5 in vitro. J. Bone Miner. Res. 12:1174-1188.
41. Vaandrager, A.B., et al. 2003. Autophosphorylation of cGMP-dependent protein kinase type II. J. Biol. Chem. 278:28651-28658.
42. Saito, T., Ikeda, T., Nakamura, K., Chung, U.I., and Kawaguchi, H. 2007. S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes. EMBO Rep. 8:504-509.